The 1st Tumor CytokinoTherapy Database (TCTD-1)

RecruitingOBSERVATIONAL

Enrollment

5,000

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

September 1, 2032

Study Completion Date

December 1, 2032

Conditions

Oncology

Interventions

DRUG

Tumor necrosis factor alpha

Antitumor agent. Immunomodulatory agent.

DRUG

Interferon gamma

Immunostimulating agent.

Trial Locations (1)

RECRUITING

OncocareClinic 308, Moscow

All Listed Sponsors

lead

OncoCareClinic 308 Ltd

OTHER